Literature DB >> 25543202

A comparison of the cardiometabolic profile of black South Africans with suspected non-alcoholic fatty liver disease (NAFLD) and excessive alcohol use.

Mandlenkosi Caswell Zatu1, Johannes Marthinus van Rooyen2, Du Toit Loots3, Minrie Greeff4, Aletta Elisabeth Schutte5.   

Abstract

Excessive alcohol use and non-alcoholic fatty liver disease (NAFLD) are putative cardiovascular disease risk factors. In order to ease the identification of these conditions on primary health care level, we aimed to determine and compare the demographic and cardiometabolic characteristics of excessive alcohol users and those with suspected NAFLD in black South Africans. In the Prospective Urban Rural Epidemiology study (North West Province, South Africa, N = 2021, collected in 2005) we selected 338 participants, namely: 1) alcohol users (N = 143) reporting 'yes' to alcohol intake, with high gamma-glutamyl transferase (GGT) ≥80 U/L and a percentage carbohydrate deficient transferrin (%CDT) ≥2%; 2) non-alcohol users (N = 127) self-reporting 'no' to alcohol intake with GGT ≤30 U/L and %CDT ≤2%; and 3) NAFLD group (N = 68) who were non-drinkers with GGT levels ≥60 U/L and %CDT ≤ 2%. The demographics indicated that the alcohol users were mostly men (73%) with a body mass index (BMI) of 19.8 (15.2-27.3) kg/m(2), 90% of which were smokers. Systolic blood pressure (SBP) of alcohol users significantly correlated with high-density lipoprotein cholesterol (HDL-C) (β = 0.24; p = 0.003) and waist circumference (WC) (β = 0.22; p = 0.006). Non-alcohol users were mostly women (84%) with a BMI of 26.0 (18.0-39.2) kg/m(2) and blood pressure in this group related positively with triglycerides. The NAFLD group were also mostly women (72%) with a comparatively larger WC (p < 0.001) and an adverse metabolic profile (total cholesterol: 5.55 ± 1.69 mmol/L; glycosylated hemoglobin: 6.03 (4.70-9.40) %). Diastolic blood pressure in the NAFLD group associated positively with WC (β = 0.27; p = 0.018). We therefore found disparate gender and cardiometabolic profiles of black South Africans with suspected NAFLD and excessive alcohol use. The described profiles may aid health care practitioners in low resource settings when using these crude screening measures of gender, obesity indices (and self-reported alcohol use) to identify individuals at risk.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood pressure; Cardiovascular disease; High-density lipoprotein cholesterol; Hypertension; Low socio economic status; Non-alcoholic steatohepatitis

Mesh:

Substances:

Year:  2014        PMID: 25543202     DOI: 10.1016/j.alcohol.2014.11.002

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  4 in total

Review 1.  Recent advances in understanding hypertension development in sub-Saharan Africa.

Authors:  A E Schutte; S Botha; C M T Fourie; L F Gafane-Matemane; R Kruger; L Lammertyn; L Malan; C M C Mels; R Schutte; W Smith; J M van Rooyen; L J Ware; H W Huisman
Journal:  J Hum Hypertens       Date:  2017-03-23       Impact factor: 3.012

2.  Monocyte Chemoattractant Protein-1 and Large Artery Structure and Function in Young Individuals: The African-PREDICT Study.

Authors:  Johanna I Kriel; Carla M T Fourie; Aletta E Schutte
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-25       Impact factor: 3.738

3.  Association between smoking and non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Authors:  Arash Akhavan Rezayat; Malihe Dadgar Moghadam; Mohammad Ghasemi Nour; Matin Shirazinia; Hamidreza Ghodsi; Mohammad Reza Rouhbakhsh Zahmatkesh; Mitra Tavakolizadeh Noghabi; Benyamin Hoseini; Kambiz Akhavan Rezayat
Journal:  SAGE Open Med       Date:  2018-01-24

Review 4.  Non-Alcoholic Fatty Liver Disease in Africa and Middle East: An Attempt to Predict the Present and Future Implications on the Healthcare System.

Authors:  Mohamed H Ahmed; Sufian K Noor; Sarra O Bushara; Nazik Elmalaika Husain; Wadie M Elmadhoun; Ibrahim A Ginawi; Meissa M Osman; Abdalhafeez O Mahmoud; Ahmed O Almobarak
Journal:  Gastroenterology Res       Date:  2017-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.